Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.68 USD | -0.59% |
|
-8.70% | -11.58% |
06/06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
05/06 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.58% | 14Cr | |
+51.63% | 80TCr | |
+40.88% | 63TCr | |
-5.10% | 36TCr | |
+19.90% | 33TCr | |
+9.95% | 30TCr | |
+17.32% | 24TCr | |
+3.80% | 23TCr | |
+12.56% | 21TCr | |
+6.99% | 17TCr |
- Stock Market
- Equities
- IMAB Stock
- News I-Mab
- I-Mab Divests China Operations, Shifts Focus to US Market